Computer Aided Detection Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

Computer Aided Detection systems are diagnostic imaging tools designed to assist radiologists and clinicians in detecting early signs of diseases such as cancer, cardiovascular conditions, and neurological disorders. The market encompasses a range of modalities including mammography CAD, lung CAD, colon CAD, and cardiovascular CAD, leveraging both traditional image-processing algorithms and modern deep learning techniques.

• •Global market valued at approximately $0.96 billion in 2025, with projections to reach roughly $1.30 billion by 2030
• •CAGR estimates for the 2025-2030 period range from approximately 5% to 6.2% across industry analyses
• •Applications span breast imaging, lung screening, colonoscopy, and cardiovascular diagnostics

The increasing global burden of cancer and other chronic diseases has led to higher volumes of medical imaging, creating demand for tools that can reduce radiologist workload and improve diagnostic accuracy. Artificial intelligence and machine learning integration have significantly enhanced CAD system performance, enabling more precise detection of subtle abnormalities.

• •Rising prevalence of breast, lung, and colorectal cancer driving demand for early detection tools
• •Shortage of skilled radiologists in many regions accelerating adoption of AI-assisted diagnostics
• •Growing emphasis on value-based healthcare and early intervention to reduce treatment costs

The market is segmented by imaging modality, with breast imaging CAD historically representing the largest segment, followed by lung and cardiovascular applications. Geographically, North America dominates due to advanced healthcare infrastructure, favorable reimbursement policies, and high AI adoption rates, while Europe and Asia-Pacific follow with expanding markets.

• •Breast CAD accounts for the largest share, with lung and colon CAD segments experiencing rapid growth
• •North America leads with roughly 40-45% of global market share, supported by FDA clearances for AI-driven CAD tools
• •Asia-Pacific is the fastest-growing region, fueled by healthcare modernization in China, India, and Japan

What are the recent trends and outlook?

The market is moving toward fully integrated AI platforms that combine CAD with computer-aided diagnosis and triage capabilities, reducing the time to identify critical findings. Cloud-based CAD solutions and interoperability standards are enabling broader deployment across diverse healthcare settings, from large academic medical centers to community hospitals.

• •Shift from standalone CAD tools to comprehensive AI-powered imaging suites with multi-modality support
• •Growing adoption of regulatory-cleared AI CAD solutions for lung cancer screening following expanded screening guidelines
• •Market consolidation expected as AI imaging startups face pressure to scale and establish clinical evidence